HEMODYNAMIC-EFFECTS OF THE USE OF ORAL SNUFF

被引:22
|
作者
HIRSCH, JM
HEDNER, J
WERNSTEDT, L
LUNDBERG, J
HEDNER, T
机构
[1] SAHLGRENS UNIV HOSP,DEPT CLIN PHARMACOL,S-41345 GOTHENBURG,SWEDEN
[2] SAHLGRENS UNIV HOSP,DEPT ORAL SURG,S-41345 GOTHENBURG,SWEDEN
[3] SAHLGRENS UNIV HOSP,DEPT PULM MED,S-41345 GOTHENBURG,SWEDEN
[4] KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN
关键词
D O I
10.1038/clpt.1992.161
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hemodynamic effects during rest and exercise of oral snuff were investigated in an open, placebo-controlled study of nine habitual users of oral snuff. Blood pressure, heart rate, and central hemodynamics were measured noninvasively. Plasma concentrations of nicotine, cotinine, norepinephrine, and epinephrine, as well as neuropeptide Y-like immunoreactivity were measured before and after snuff intake during rest and exercise. Snuff intake induced a significant increase in heart rate and blood pressure and a decrease in stroke volume during rest. Hemodynamic changes were unrelated to nicotine or cotinine concentrations. Resting levels of norepinephrine and neuropeptide Y-like immunoreactivity were similar with or without snuff, whereas epinephrine was slightly increased 30 minutes after snuff intake. The exercise-induced increase in norepinephrine and neuropeptide Y-like immunoreactivity did not differ between the days subjects received snuff and the days they received placebo. In contrast, maximum work load was associated with a slight increase in circulating epinephrine after snuff intake. The findings suggest that snuff intake is associated with significant hemodynamic effects during rest but not during exercise. These effects could not be readily explained by activation of the sympathetic nervous system.
引用
收藏
页码:394 / 401
页数:8
相关论文
共 50 条
  • [31] HEMODYNAMIC-EFFECTS OF FELODIPINE
    不详
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 : S49 - S49
  • [32] HEMODYNAMIC-EFFECTS OF CARBOCHROMEN
    FRANCHI, F
    MICHELUCCI, A
    PADELETTI, L
    FANTINI, F
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1980, 28 (02): : 243 - 252
  • [33] HEMODYNAMIC-EFFECTS OF PERINDOPRIL
    BENETOS, A
    LEVY, B
    ASMAR, R
    SAFAR, M
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1989, 38 (7BIS): : 483 - 486
  • [34] HEMODYNAMIC-EFFECTS OF MEXILETINE
    DELFINO, M
    PALANGE, P
    TENEGGI, V
    ANGELICI, E
    CARLONE, S
    SERRA, P
    CLINICAL RESEARCH, 1983, 31 (04): : A704 - A704
  • [35] HEMODYNAMIC-EFFECTS OF BRADYKININ
    PEPPER, JR
    BOERBOOM, LE
    WERNER, PH
    OLINGER, GN
    BONCHEK, LI
    SURGICAL FORUM, 1979, 30 : 26 - 27
  • [36] HEMODYNAMIC-EFFECTS OF MEXILETINE
    VALLOT, F
    PAGE, A
    BESSE, P
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1979, 72 (12): : 1359 - 1366
  • [37] HEMODYNAMIC-EFFECTS OF MOLSIDOMINE
    RAKOVEC, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1980, 2 (06) : 893 - 894
  • [38] HEMODYNAMIC-EFFECTS OF NITROGLYCERIN
    FANTINI, F
    DABIZZI, RP
    FRANCHI, F
    MICHELUCCI, A
    PADELETTI, L
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, 1979, 17 (11): : 449 - 452
  • [39] HEMODYNAMIC-EFFECTS OF PRENALTEROL
    DAHLSTROM, U
    KARLSSON, E
    WRANNE, B
    ACTA MEDICA SCANDINAVICA, 1982, : 36 - 36
  • [40] HEMODYNAMIC-EFFECTS OF NITROGLYCERIN
    KUKES, VG
    ZISELMAN, SB
    BURIAN, EF
    CHUONG, V
    KIREEVA, NA
    MITROFANOV, VA
    KLINICHESKAYA MEDITSINA, 1981, 59 (11): : 22 - 25